Acute respiratory failure complicating advanced liver disease

Seminars in Respiratory and Critical Care Medicine

Volumn 33, Issue 1, 2012, Pages 96-110

  Karcz, Marcin ^a   Bankey, Bridget ^a   Schwaiberger, David ^b   Lachmann, Burkhard ^b   Papadakos, Peter J ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

acute respiratory distress syndrome; cirrhosis; hepatic hydrothorax; hepatopulmonary syndrome; portopulmonary hypertension; respiratory failure

Indexed keywords

ACUTE RESPIRATORY FAILURE; ARTICLE; ARTIFICIAL VENTILATION; CRITICALLY ILL PATIENT; DECOMPENSATED LIVER CIRRHOSIS; DISEASE ASSOCIATION; HEPATOPULMONARY SYNDROME; HUMAN; HYDROTHORAX; HYPOXEMIA; INTENSIVE CARE UNIT; LIVER CIRRHOSIS; LIVER DISEASE; MORTALITY; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; PORTOPULMONARY HYPERTENSION; PRIORITY JOURNAL; RESPIRATORY DISTRESS;

ANOXIA; END STAGE LIVER DISEASE; HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; LIVER CIRRHOSIS; LIVER FAILURE, ACUTE; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84858731561     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0032-1301738     Document Type: Article

References (243)

1. Young-Hee Y, Hsiao-ye Y. Liver cirrhosis mortality in the United States, 1970-2007. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; August: 2010; http://pubs.niaaa.nih.gov/publications/surveillance88/ cirr07.htm. Accessed July 1, 2011
2. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol: 2006; 44 1 217 231 (Pubitemid 41772537)
3. Agusti AGN, Roca J, Rodriguez-Roisin R. Mechanisms of gas exchange impairment in patients with liver cirrhosis. Clin Chest Med: 1996; 17 1 49 66 (Pubitemid 26100793)
4. Chao Y, Wang SS, Lee SD, Shiao GM, Chang HI, Chang SC. Effect of large-volume paracentesis on pulmonary function in patients with cirrhosis and tense ascites. J Hepatol: 1994; 20 1 101 105 (Pubitemid 24043093)
5. Angueira CE, Kadakia SC. Effects of large-volume paracentesis on pulmonary function in patients with tense cirrhotic ascites. Hepatology: 1994; 20 4 Pt 1 825 828 (Pubitemid 24296487)
6. Agust AGN, Roca J, Bosch J, Rodriguez-Roisin R. The lung in patients with cirrhosis. J Hepatol: 1990; 10 2 251 257 (Pubitemid 20089170)
7. Krowka MJ, Cortese DA. Pulmonary aspects of chronic liver disease and liver transplantation. Mayo Clin Proc: 1985; 60 6 407 418 (Pubitemid 15232991)
8. Mller S, Hillings J, Christensen E, Henriksen JH. Arterial hypoxaemia in cirrhosis: fact or fiction? Gut: 1998; 42 6 868 874 (Pubitemid 28277231)
9. Martnez GP, Barber JA, Visa J., et al. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol: 2001; 34 5 651 657 (Pubitemid 32488779)
10. Hourani JM, Bellamy PE, Tashkin DP, Batra P, Simmons MS. Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity. Am J Med: 1991; 90 6 693 700
11. Naeije R, Mlot C, Hallemands R, Mols P, Lejeune P. Pulmonary hemodynamics in liver cirrhosis. Semin Respir Med: 1985; 7 164 170 (Pubitemid 16241429)
12. Keys A, Snell AM. Respiratory properties of the arterial blood in normal men and in patients with disease of the liver: position of the oxygen dissociation curve. J Clin Invest: 1938; 17 1 59 67
13. Caldwell PRB, Fritts HW Jr, Cournand A. Oxyhemoglobin dissociation curve in liver cirrhosis. J Appl Physiol: 1965; 20 316 320
14. Zimmon DS. Oxyhemoglobin dissociation in patients with hepatic encephalopathy. Gastroenterology: 1967; 52 4 647 654
15. Astrup J, Rörth M. Oxygen affinity of hemoglobin and red cell 2,3-diphosphoglycerate in hepatic cirrhosis. Scand J Clin Lab Invest: 1973; 31 3 311 317
16. Heinemann HO, Emirgil C, Mijnssen JP. Hyperventilation and arterial hypoxemia in cirrhosis of the liver. Am J Med: 1960; 28 239 246
17. Rodman T, Sobel M, Close HP. Arterial oxygen unsaturation and the ventilation-perfusion defect of Laennec's cirrhosis. N Engl J Med: 1960; 263 73 77
18. Karetzky MS, Mithoefer JC. The cause of hyperventilation and arterial hypoxia in patients with cirrhosis of the liver. Am J Med Sci: 1967; 254 6 797 804
19. Abelman WH, Kramer GE, Verstraeten JM., et al. Cirrhosis of the liver and decreased arterial oxygen saturation. Arch Intern Med: 1961; 108 102 108
20. Massumi RA, Rios JC, Ticktin HE. Hemodynamic abnormalities and venous admixture in portal cirrhosis. Am J Med Sci: 1965; 250 3 275 283
21. Mellemgaard K, Winkler K, Tygstrup N, Georg J. Sources of venoarterial admixture in portal hypertension. J Clin Invest: 1963; 42 1399 1405
22. Wilson RH, Ebert RV, Borden CW., et al. The determinations of blood flow through nonventilated portions of the normal and diseased lung. Am Rev Tuberc: 1953; 68 2 177 187
23. Fritts HW Jr, Hardewig A, Rochester DF, Durand J, Cournand A. Estimation of pulmonary arteriovenous shunt-flow using intravenous injections of T-1824 dye and Kr85. J Clin Invest: 1960; 39 1841 1850
24. Eriksson LS, Söderman C, Ericzon BG, Eleborg L, Wahren J, Hedenstierna G. Normalization of ventilation/perfusion relationships after liver transplantation in patients with decompensated cirrhosis: evidence for a hepatopulmonary syndrome. Hepatology: 1990; 12 6 1350 1357
25. Hedenstierna G, Söderman C, Eriksson LS, Wahren J. Ventilation-perfusion inequality in patients with non-alcoholic liver cirrhosis. Eur Respir J: 1991; 4 6 711 717
26. Herv P, Lebrec D, Brenot F., et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J: 1998; 11 5 1153 1166 (Pubitemid 28281039)
27. Mller S, Becker U, Schifter S, Abrahamsen J, Henriksen JH. Effect of oxygen inhalation on systemic, central, and splanchnic haemodynamics in cirrhosis. J Hepatol: 1996; 25 3 316 328 (Pubitemid 26323470)
28. Söderman C, Eriksson LS, Juhlin-Dannfelt A, Lundberg JM, Broman L, Holmgren A. Effect of vasoactive intestinal polypeptide (VIP) on pulmonary ventilation-perfusion relationships and central haemodynamics in healthy subjects. Clin Physiol: 1993; 13 6 677 685 (Pubitemid 23338318)
29. Söderman C, Juhlin-Dannfelt A, Lagerstrand L, Eriksson LS. Ventilation-perfusion relationships and central haemodynamics in patients with cirrhosis: effects of a somatostatin analogue. J Hepatol: 1994; 21 1 52 57 (Pubitemid 24236680)
30. Rodriguez-Roisin R, Roca J, Agusti AGN, Mastai R, Wagner PD, Bosch J. Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis: 1987; 135 5 1085 1092 (Pubitemid 18021494)
31. Mlot C, Naeije R, Dechamps P, Hallemans R, Lejeune P. Pulmonary and extrapulmonary contributors to hypoxemia in liver cirrhosis. Am Rev Respir Dis: 1989; 139 3 632 640 (Pubitemid 19084382)
32. Ruff F, Hughes JMB, Stanley N., et al. Regional lung function in patients with hepatic cirrhosis. J Clin Invest: 1971; 50 11 2403 2413
33. Daoud FS, Reeves JT, Schaefer JW. Failure of hypoxic pulmonary vasoconstriction in patients with liver cirrhosis. J Clin Invest: 1972; 51 5 1076 1080
34. Krowka MJ. Hepatopulmonary syndromes. Gut: 2000; 46 1 1 4 (Pubitemid 30307664)
35. Fallon MB, Abrams GA. Pulmonary dysfunction in chronic liver disease. Hepatology: 2000; 32 4 Pt 1 859 865
36. Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC.; Official Statement of the European Respiratory Society. Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Eur Respir J Suppl: 1993; 16 41 52
37. Mller S, Burchardt H, gard CG, Schidt FV, Lund JO. Pulmonary blood volume and transit time in cirrhosis: relation to lung function. Liver Int: 2006; 26 9 1072 1078 (Pubitemid 44541748)
38. Katsuta Y, Honma H, Zhang XJ., et al. Pulmonary blood transit time and impaired arterial oxygenation in patients with chronic liver disease. J Gastroenterol: 2005; 40 1 57 63 (Pubitemid 40796333)
39. Gmez FP, Martnez-Pall G, Barber JA, Roca J, Navasa M, Rodrguez-Roisin R. Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome. Hepatology: 2004; 40 3 660 666 (Pubitemid 39265588)
40. Singh N, Gayowski T, Wagener MM, Marino IR. Outcome of patients with cirrhosis requiring intensive care unit support: prospective assessment of predictors of mortality. J Gastroenterol: 1998; 33 1 73 79 (Pubitemid 28067778)
41. Kress JP, Rubin A, Pohlman AS, Hall JB. Outcomes of critically ill patients denied consideration for liver transplantation. Am J Respir Crit Care Med: 2000; 162 2 Pt 1 418 423 (Pubitemid 30647176)
42. Aggarwal A, Ong JP, Younossi ZM, Nelson DR, Hoffman-Hogg L, Arroliga AC. Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU. Chest: 2001; 119 5 1489 1497 (Pubitemid 32686034)
43. Levy MF, Greene L, Ramsay MA., et al. Readmission to the intensive care unit after liver transplantation. Crit Care Med: 2001; 29 1 18 24 (Pubitemid 32125768)
44. Ramachandran A, Balasubramanian KA. Intestinal dysfunction in liver cirrhosis: its role in spontaneous bacterial peritonitis. J Gastroenterol Hepatol: 2001; 16 6 607 612 (Pubitemid 34188833)
45. Westphal J-F, Jehl F, Vetter D. Pharmacological, toxicologic, and microbiological considerations in the choice of initial antibiotic therapy for serious infections in patients with cirrhosis of the liver. Clin Infect Dis: 1994; 18 3 324 335 (Pubitemid 24086300)
46. Przybyowski T, Krenke R, Fangrat A., et al. Gas exchange abnormalities in patients listed for liver transplantation. J Physiol Pharmacol: 2006; 57 Suppl 4 313 323 (Pubitemid 44638215)
47. Mohamed R, Freeman JW, Guest PJ, Davies MK, Neuberger JM. Pulmonary gas exchange abnormalities in liver transplant candidates. Liver Transpl: 2002; 8 9 802 808 (Pubitemid 35012291)
48. Johnson DH, Cunha BA. Infections in cirrhosis. Infect Dis Clin North Am: 2001; 15 2 363 371, vii (Pubitemid 32606904)
49. Wallaert B, Aerts C, Colombel JF, Voisin C. Human alveolar macrophage antibacterial activity in the alcoholic lung. Am Rev Respir Dis: 1991; 144 2 278 283
50. Gosset P, Wallaert B, Canva-Delcambre V, Colombel JF, Tonnel AB. Impaired secretion and mRNA expression of monokines by alveolar macrophages from nonsmoking patients with alcoholic liver cirrhosis. J Infect Dis: 1995; 171 3 743 746
51. Wallaert B, Colombel JF, Prin L, Sibille Y, Tonnel AB. Bronchoalveolar lavage in alcoholic liver cirrhosis. T-lymphocyte subsets and immunoglobulin concentrations. Chest: 1992; 101 2 468 473
52. Doyle HR, Marino IR, Miro A., et al. Adult respiratory distress syndrome secondary to end-stage liver disease-successful outcome following liver transplantation. Transplantation: 1993; 55 2 292 296 (Pubitemid 23065457)
53. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med: 1995; 152 6 Pt 1 1818 1824
54. TenHoor T, Mannino DM, Moss M. Risk factors for ARDS in the United States: analysis of the 1993 National Mortality Followback Study. Chest: 2001; 119 4 1179 1184 (Pubitemid 32679448)
55. Montgomery AB, Stager MA, Carrico CJ, Hudson LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis: 1985; 132 3 485 489 (Pubitemid 15247959)
56. Fowler AA, Hamman RF, Zerbe GO, Benson KN, Hyers TM. Adult respiratory distress syndrome. Prognosis after onset. Am Rev Respir Dis: 1985; 132 3 472 478 (Pubitemid 15247957)
57. Seidenfeld JJ, Pohl DF, Bell RC, Harris GD, Johanson WG Jr. Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome. Am Rev Respir Dis: 1986; 134 1 12 16 (Pubitemid 16057452)
58. Hyers TM, Fowler AA. Adult respiratory distress syndrome: causes, morbidity, and mortality. Fed Proc: 1986; 45 1 25 29 (Pubitemid 16027146)
59. Phua J, Badia JR, Adhikari NK., et al. Has mortality from acute respiratory distress syndrome decreased over time?: a systematic review. Am J Respir Crit Care Med: 2009; 179 3 220 227
60. Zambon M, Vincent JL. Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest: 2008; 133 5 1120 1127 (Pubitemid 351685515)
61. Cholongitas E, Senzolo M, Patch D., et al. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther: 2006; 23 7 883 893
62. Das V, Boelle PY, Galbois A., et al. Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival. Crit Care Med: 2010; 38 11 2108 2116
63. Findlay JY, Fix OK, Paugam-Burtz C., et al. Critical care of the end-stage liver disease patient awaiting liver transplantation. Liver Transpl: 2011; 17 5 496 510
64. Matuschak GM, Rinaldo JE, Pinsky MR., et al. Effects of end-stage liver failure on the incidence and resolution of the adult respiratory distress syndrome. J Crit Care: 1987; 2 162 173
65. Monchi M, Bellenfant F, Cariou A., et al. Early predictive factors of survival in the acute respiratory distress syndrome: a multivariate analysis. Am J Respir Crit Care Med: 1998; 158 4 1076 1081 (Pubitemid 28489004)
66. Rouby JJ, Puybasset L, Cluzel P, Richecoeur J, Lu Q, Grenier P.; CT Scan ARDS Study Group. Regional distribution of gas and tissue in acute respiratory distress syndrome, II: Physiological correlations and definition of an ARDS Severity Score. Intensive Care Med: 2000; 26 8 1046 1056
67. Gattinoni L, Caironi P, Pelosi P, Goodman LR. What has computed tomography taught us about the acute respiratory distress syndrome? Am J Respir Crit Care Med: 2001; 164 9 1701 1711 (Pubitemid 33124162)
68. Pelosi P, D'Andrea L, Vitale G, Pesenti A, Gattinoni L. Vertical gradient of regional lung inflation in adult respiratory distress syndrome. Am J Respir Crit Care Med: 1994; 149 1 8 13 (Pubitemid 24066089)
69. Puybasset L, Cluzel P, Chao N, Slutsky AS, Coriat P, Rouby JJ.; The CT Scan ARDS Study Group. A computed tomography scan assessment of regional lung volume in acute lung injury. Am J Respir Crit Care Med: 1998; 158 5 Pt 1 1644 1655
70. Matuschak GM, Rinaldo JE. Organ interactions in the adult respiratory distress syndrome during sepsis: role of the liver in host defense. Chest: 1988; 94 2 400 406
71. Bell RC, Coalson JJ, Smith JD, Johanson WG Jr. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med: 1983; 99 3 293 298
72. Matuschak GM. Lung-liver interactions in sepsis and multiple organ failure syndrome. Clin Chest Med: 1996; 17 1 83 98 (Pubitemid 26100795)
73. Ruiter DJ, van der Meulen J, Brouwer A., et al. Uptake by liver cells of endotoxin following its intravenous injection. Lab Invest: 1981; 45 1 38 45 (Pubitemid 11059989)
74. Saldeen T. Clotting, microembolism, and inhibition of fibrinolysis in adult respiratory distress. Surg Clin North Am: 1983; 63 2 285 304 (Pubitemid 13093178)
75. Bradfield JWB. Control of spillover: the importance of Kupffer-cell function in clinical medicine. Lancet: 1974; 2 7885 883 886
76. Wardle EN. Kupffer cells and their function. Liver: 1987; 7 2 63 75 (Pubitemid 17112157)
77. Yokoyama I, Todo S, Miyata T, Selby R, Tzakis AG, Starzl TE. Endotoxemia and human liver transplantation. Transplant Proc: 1989; 21 5 3833 3841 (Pubitemid 20266945)
78. Miyata T, Yokoyama I, Todo S, Tzakis A, Selby R, Starzl TE. Endotoxaemia, pulmonary complications, and thrombocytopenia in liver transplantation. Lancet: 1989; 2 8656 189 191 (Pubitemid 19186999)
79. Altomare E, Vendemiale G, Albano O. Hepatic glutathione content in patients with alcoholic and non alcoholic liver diseases. Life Sci: 1988; 43 12 991 998
80. Moss M, Guidot DM, Wong-Lambertina M, Ten Hoor T, Perez RL, Brown LA. The effects of chronic alcohol abuse on pulmonary glutathione homeostasis. Am J Respir Crit Care Med: 2000; 161 2 Pt 1 414 419 (Pubitemid 30129446)
81. Rahman Q, Abidi P, Afaq F., et al. Glutathione redox system in oxidative lung injury. Crit Rev Toxicol: 1999; 29 6 543 568
82. Kaplan JE, Saba TM. Platelet removal from the circulation by the liver and spleen. Am J Physiol: 1978; 235 3 H314 H320 (Pubitemid 9159904)
83. Matuschak GM, Pinsky MR, Klein EC, Van Thiel DH, Rinaldo JE. Effects of D-galactosamine-induced acute liver injury on mortality and pulmonary responses to Escherichia coli lipopolysaccharide. Modulation by arachidonic acid metabolites. Am Rev Respir Dis: 1990; 141 5 Pt 1 1296 1306 (Pubitemid 20172587)
84. Goldfarb G, Nouel O, Poynard T, Rueff B. Efficiency of respiratory assistance in cirrhotic patients with liver failure. Intensive Care Med: 1983; 9 5 271 273 (Pubitemid 13045812)
85. Lee KC, Chiang AA. The outcome of terminal liver cirrhosis patients requiring mechanical ventilation. Zhonghua Yi Xue Za Zhi (Taipei): 1997; 59 2 88 94
86. Moreau R, Hadengue A, Soupison T., et al. Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcome. Crit Care Med: 1992; 20 6 746 750
87. Shellman RG, Fulkerson WJ, DeLong E, Piantadosi CA. Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit. Crit Care Med: 1988; 16 7 671 678
88. Castera L, Pauwels A, Lvy VG. Prognostic indicators in patients with liver cirrhosis admitted to an intensive care unit [in French]. Gastroenterol Clin Biol: 1996; 20 3 263 268 (Pubitemid 26173463)
89. Foreman MG, Mannino DM, Moss M. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest: 2003; 124 3 1016 1020 (Pubitemid 37123324)
90. Zauner CA, Apsner RC, Kranz A., et al. Outcome prediction for patients with cirrhosis of the liver in a medical ICU: a comparison of the APACHE scores and liver-specific scoring systems. Intensive Care Med: 1996; 22 6 559 563 (Pubitemid 26202598)
91. Rabe C, Schmitz V, Paashaus M., et al. Does intubation really equal death in cirrhotic patients? Factors influencing outcome in patients with liver cirrhosis requiring mechanical ventilation. Intensive Care Med: 2004; 30 8 1564 1571 (Pubitemid 39094957)
92. Amato MB, Barbas CS, Medeiros DM., et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med: 1998; 338 6 347 354 (Pubitemid 28083906)
93. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med: 2000; 342 18 1301 1308
94. Brochard L, Roudot-Thoraval F, Roupie E., et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trial Group on Tidal Volume Reduction in ARDS. Am J Respir Crit Care Med: 1998; 158 6 1831 1838 (Pubitemid 29008822)
95. Stewart TE, Meade MO, Cook DJ., et al. Pressure- and Volume-Limited Ventilation Strategy Group. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. N Engl J Med: 1998; 338 6 355 361 (Pubitemid 28083907)
96. Brower RG, Shanholtz CB, Fessler HE., et al. Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med: 1999; 27 8 1492 1498 (Pubitemid 29406938)
97. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med: 2003; 31 4, Suppl S213 S220 (Pubitemid 36458170)
98. Gattinoni L, Mascheroni D, Torresin A., et al. Morphological response to positive end expiratory pressure in acute respiratory failure: computerized tomography study. Intensive Care Med: 1986; 12 3 137 142 (Pubitemid 16118208)
99. Ranieri VM, Suter PM, Tortorella C., et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA: 1999; 282 1 54 61 (Pubitemid 29318933)
100. Ranieri VM, Giunta F, Suter PM, Slutsky AS. Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA: 2000; 284 1 43 44 (Pubitemid 30445657)
101. Headley AS, Tolley E, Meduri GU. Infections and the inflammatory response in acute respiratory distress syndrome. Chest: 1997; 111 5 1306 1321 (Pubitemid 27200090)
102. Roumen RM, Hendriks T, van der Ven-Jongekrijg J., et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg: 1993; 218 6 769 776 (Pubitemid 24005822)
103. Stüber F, Wrigge H, Schroeder S., et al. Kinetic and reversibility of mechanical ventilation-associated pulmonary and systemic inflammatory response in patients with acute lung injury. Intensive Care Med: 2002; 28 7 834 841 (Pubitemid 34762216)
104. Dreyfuss D, Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med: 1998; 157 1 294 323 (Pubitemid 28071297)
105. Brower RG, Lanken PN, MacIntyre N., et al. National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med: 2004; 351 4 327 336
106. Rodrguez-Roisin R, Krowka MJ, Herv P, Fallon MB.; ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J: 2004; 24 5 861 880 (Pubitemid 39504442)
107. Funk GC, Doberer D, Kneidinger N, Lindner G, Holzinger U, Schneeweiss B. Acid-base disturbances in critically ill patients with cirrhosis. Liver Int: 2007; 27 7 901 909 (Pubitemid 47261943)
108. Pinsky MR. The hemodynamic consequences of mechanical ventilation: an evolving story. Intensive Care Med: 1997; 23 5 493 503 (Pubitemid 27263060)
109. Brienza N, Revelly JP, Ayuse T, Robotham JL. Effects of PEEP on liver arterial and venous blood flows. Am J Respir Crit Care Med: 1995; 152 2 504 510
110. Winsö O, Biber B, Gustavsson B, Holm C, Milsom I, Niemand D. Portal blood flow in man during graded positive end-expiratory pressure ventilation. Intensive Care Med: 1986; 12 2 80 85 (Pubitemid 16162643)
111. Matuschak GM, Pinsky MR, Rogers RM. Effects of positive end-expiratory pressure on hepatic blood flow and performance. J Appl Physiol: 1987; 62 4 1377 1383 (Pubitemid 17070414)
112. Varpula T, Valta P, Niemi R, Takkunen O, Hynynen M, Pettilä VV. Airway pressure release ventilation as a primary ventilatory mode in acute respiratory distress syndrome. Acta Anaesthesiol Scand: 2004; 48 6 722 731 (Pubitemid 38843392)
113. Bollen CW, van Well GT, Sherry T., et al. High frequency oscillatory ventilation compared with conventional mechanical ventilation in adult respiratory distress syndrome: a randomized controlled trial [ISRCTN24242669]. Crit Care: 2005; 9 4 R430 R439
114. Sun HY, Cacciarelli TV, Singh N. Impact of pretransplant infections on clinical outcomes of liver transplant recipients. Liver Transpl: 2010; 16 2 222 228
115. Adhikari NK, Burns KE, Friedrich JO, Granton JT, Cook DJ, Meade MO. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ: 2007; 334 7597 779
116. Burns KE, Adhikari NK, Keenan SP, Meade M. Use of non-invasive ventilation to wean critically ill adults off invasive ventilation: meta-analysis and systematic review. BMJ: 2009; 338 b1574
117. Antonelli M, Conti G, Bufi M., et al. Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial. JAMA: 2000; 283 2 235 241 (Pubitemid 30039224)
118. Hilbert G, Gruson D, Vargas F., et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med: 2001; 344 7 481 487 (Pubitemid 32164899)
119. Narita M, Hatano E, Nagata H., et al. Prophylactic respiratory management after liver resection with bilevel positive airway pressure ventilation: report of three cases. Surg Today: 2009; 39 2 172 174
120. Nagai S, Fujimoto Y, Kamei H, Nakamura T, Kiuchi T. Noninvasive positive pressure ventilation to prevent respiratory collapse after extubation: clinical case reports. Transplant Proc: 2009; 41 9 3919 3922
121. Gunnarsson L, Tokics L, Gustavsson H, Hedenstierna G. Influence of age on atelectasis formation and gas exchange impairment during general anaesthesia. Br J Anaesth: 1991; 66 4 423 432
122. Hedenstierna G, Tokics L, Strandberg A, Lundquist H, Brismar B. Correlation of gas exchange impairment to development of atelectasis during anaesthesia and muscle paralysis. Acta Anaesthesiol Scand: 1986; 30 2 183 191 (Pubitemid 16162630)
123. Jensen AG, Kalman SH, Eintrei C, Fransson SG, Morales O. Atelectasis and oxygenation in major surgery with either propofol with or without nitrous oxide or isoflurane anaesthesia. Anaesthesia: 1993; 48 12 1094 1096 (Pubitemid 24002407)
124. Rothen HU, Sporre B, Engberg G, Wegenius G, Högman M, Hedenstierna G. Influence of gas composition on recurrence of atelectasis after a reexpansion maneuver during general anesthesia. Anesthesiology: 1995; 82 4 832 842
125. Tenling A, Hachenberg T, Tydn H, Wegenius G, Hedenstierna G. Atelectasis and gas exchange after cardiac surgery. Anesthesiology: 1998; 89 2 371 378 (Pubitemid 28373426)
126. Tusman G, Böhm SH, Tempra A., et al. Effects of recruitment maneuver on atelectasis in anesthetized children. Anesthesiology: 2003; 98 1 14 22 (Pubitemid 36043403)
127. Mead J, Takishima T, Leith D. Stress distribution in lungs: a model of pulmonary elasticity. J Appl Physiol: 1970; 28 5 596 608
128. Seeger W, Günther A, Walmrath HD, Grimminger F, Lasch HG. Alveolar surfactant and adult respiratory distress syndrome: pathogenetic role and therapeutic prospects. Clin Investig: 1993; 71 3 177 190 (Pubitemid 23077027)
129. Pinhu L, Whitehead T, Evans T, Griffiths M. Ventilator-associated lung injury. Lancet: 2003; 361 9354 332 340 (Pubitemid 36126199)
130. Verbrugge SJC, Lachmann B. Surfactant replacement therapy in experimental and clinical studies. Appl Cardiopulm Pathophysiol: 1998; 7 237 250 (Pubitemid 29078497)
131. Hartog A, Gommers D, Verbrugge SJ., et al. Maintaining high lung volume during surfactant depletion attenuates the decrease in lung function. Intensive Care Med: 1997; 23 S13
132. Hartog A, Vazquez de Anda GF, Gommers D, Kaisers U, Lachmann B. At surfactant deficiency, application of "the open lung concepto" prevents protein leakage and attenuates changes in lung mechanics. Crit Care Med: 2000; 28 5 1450 1454 (Pubitemid 30324522)
133. Lachmann B, Danzmann E, Haendly B., et al. Ventilator settings and gas exchange in respiratory distress syndrome. In: Prakash O., ed. Applied Physiology in Clinical Respiratory Care. The Hague Martinus Nijhoff: 1982; 141 176
134. Papadakos PJ, Lachmann B. The open lung concept of alveolar recruitment can improve outcome in respiratory failure and ARDS. Mt Sinai J Med: 2002; 69 1-2 73 77 (Pubitemid 34092644)
135. Halter JM, Steinberg JM, Schiller HJ., et al. Positive end-expiratory pressure after a recruitment maneuver prevents both alveolar collapse and recruitment/derecruitment. Am J Respir Crit Care Med: 2003; 167 12 1620 1626 (Pubitemid 36760674)
136. Schreiter D, Reske A, Scheibner L, Glien C, Katscher S, Josten C. The open lung concept: clinical application in severe thoracic trauma [in German]. Chirurg: 2002; 73 4 353 359
137. van Kaam AH, de Jaegere A, Haitsma JJ, Van Aalderen WM, Kok JH, Lachmann B. Positive pressure ventilation with the open lung concept optimizes gas exchange and reduces ventilator-induced lung injury in newborn piglets. Pediatr Res: 2003; 53 2 245 253 (Pubitemid 36177120)
138. Reis Miranda D, Struijs A, Koetsier P., et al. Open lung ventilation improves functional residual capacity after extubation in cardiac surgery. Crit Care Med: 2005; 33 10 2253 2258 (Pubitemid 41437479)
139. Haitsma JJ, Uhlig S, Göggel R, Verbrugge SJ, Lachmann U, Lachmann B. Ventilator-induced lung injury leads to loss of alveolar and systemic compartmentalization of tumor necrosis factor-alpha. Intensive Care Med: 2000; 26 10 1515 1522
140. Verbrugge SJ, Sorm V, van 't Veen A, Mouton JW, Gommers D, Lachmann B. Lung overinflation without positive end-expiratory pressure promotes bacteremia after experimental Klebsiella pneumoniae inoculation. Intensive Care Med: 1998; 24 2 172 177 (Pubitemid 28190772)
141. Rouby JJ, Constantin JM, Roberto De A Girardi C, Zhang M, Lu Q. Mechanical ventilation in patients with acute respiratory distress syndrome. Anesthesiology: 2004; 101 1 228 234 (Pubitemid 38833285)
142. Abelmann WH, Frank NR, Gaensler EA, Cugell DW. Effects of abdominal distention by ascites on lung volumes and ventilation. AMA Arch Intern Med: 1954; 93 4 528 540
143. Angueira CE, Kadakia SC. Effects of large-volume paracentesis on pulmonary function in patients with tense cirrhotic ascites. Hepatology: 1994; 20 4 Pt 1 825 828 (Pubitemid 24296487)
144. Byrd RP Jr, Roy TM, Simons M. Improvement in oxygenation after large volume paracentesis. South Med J: 1996; 89 7 689 692 (Pubitemid 26250099)
145. Gupta D, Lalrothuama Agrawal PN., et al. Pulmonary function changes after large volume paracentesis. Trop Gastroenterol: 2000; 21 2 68 70
146. Chao Y, Wang SS, Lee SD, Shiao GM, Chang HI, Chang SC. Effect of large-volume paracentesis on pulmonary function in patients with cirrhosis and tense ascites. J Hepatol: 1994; 20 1 101 105 (Pubitemid 24043093)
147. Duranti R, Laffi G, Misuri G., et al. Respiratory mechanics in patients with tense cirrhotic ascites. Eur Respir J: 1997; 10 7 1622 1630 (Pubitemid 27311082)
148. Haitsma JJ, Lachmann RA, Lachmann B. Open lung in ARDS. Acta Pharmacol Sin: 2003; 24 12 1304 1307 (Pubitemid 37509443)
149. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med: 2000; 342 18 1334 1349 (Pubitemid 30408719)
150. Grasso S, Mascia L, Del Turco M., et al. Effects of recruiting maneuvers in patients with acute respiratory distress syndrome ventilated with protective ventilatory strategy. Anesthesiology: 2002; 96 4 795 802 (Pubitemid 34266671)
151. Constantin JM, Grasso S, Chanques G., et al. Lung morphology predicts response to recruitment maneuver in patients with acute respiratory distress syndrome. Crit Care Med: 2010; 38 4 1108 1117
152. Brochard L, Roudot-Thoraval F, Roupie E., et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trial Group on Tidal Volume Reduction in ARDS. Am J Respir Crit Care Med: 1998; 158 6 1831 1838 (Pubitemid 29008822)
153. Larsen FS, Hansen BA, Blei AT. Intensive care management of patients with acute liver failure with emphasis on systemic hemodynamic instability and cerebral edema: a critical appraisal of pathophysiology. Can J Gastroenterol: 2000; 14 Suppl 0D 105D 111D
154. Kramer DJ, Aggarwal S, Martin M., et al. Management options in fulminant hepatic failure. Transplant Proc: 1991; 23 3 1895 1898
155. Stravitz RT, Kramer DJ. Management of acute liver failure. Nat Rev Gastroenterol Hepatol: 2009; 6 9 542 553
156. Bonnet F, Richard C, Glaser P, Lafay M, Guesde R. Changes in hepatic flow induced by continuous positive pressure ventilation in critically ill patients. Crit Care Med: 1982; 10 11 703 705
157. Wendon JA, Harrison PM, Keays R, Williams R. Cerebral blood flow and metabolism in fulminant liver failure. Hepatology: 1994; 19 6 1407 1413 (Pubitemid 24166461)
158. Strauss GI, Hgh P, Mller K, Knudsen GM, Hansen BA, Larsen FS. Regional cerebral blood flow during mechanical hyperventilation in patients with fulminant hepatic failure. Hepatology: 1999; 30 6 1368 1373
159. Strauss G, Hansen BA, Knudsen GM, Larsen FS. Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure. J Hepatol: 1998; 28 2 199 203 (Pubitemid 28116427)
160. Kennedy TC, Knudson RJ. Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis. Chest: 1977; 72 3 305 309 (Pubitemid 8217614)
161. Fluckiger M. Vorkommen von trommelschlägelförmigen Fingerendphalangen ohne chronische Veränderungen an der Lungen oder am Herzen. Wien Med Wochenschr: 1884; 34 1457
162. Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet: 2004; 363 9419 1461 1468 (Pubitemid 38586724)
163. Krowka MJ, Cortese DA. Hepatopulmonary syndrome: current concepts in diagnostic and therapeutic considerations. Chest: 1994; 105 5 1528 1537 (Pubitemid 24152616)
164. Colle I, Van Steenkiste C, Geerts A, Van Vlierberghe H. Hepatopulmonary syndrome and portopulmonary hypertension: what's new? Acta Gastroenterol Belg: 2007; 70 2 203 209 (Pubitemid 47066273)
165. Rodrguez-Roisin R, Krowka MJ. Hepatopulmonary syndromea liver-induced lung vascular disorder. N Engl J Med: 2008; 358 22 2378 2387
166. Krowka MJ, Cortese DA. Pulmonary aspects of liver disease and liver transplantation. Clin Chest Med: 1989; 10 4 593 616 (Pubitemid 20014956)
167. Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med: 1995; 122 7 521 529
168. Schenk P, Schöniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Müller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology: 2003; 125 4 1042 1052 (Pubitemid 37193451)
169. Krowka MJ, Tajik AJ, Dickson ER, Wiesner RH, Cortese DA. Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates: screening by two-dimensional contrast-enhanced echocardiography. Chest: 1990; 97 5 1165 1170 (Pubitemid 20166810)
170. Stoller JK, Lange PA, Westveer MK, Carey WD, Vogt D, Henderson JM. Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience. West J Med: 1995; 163 2 133 138
171. Hopkins WE, Waggoner AD, Barzilai B. Frequency and significance of intrapulmonary right-to-left shunting in end-stage hepatic disease. Am J Cardiol: 1992; 70 4 516 519
172. Arguedas MR, Singh H, Faulk DK, Fallon MB. Utility of pulse oximetry screening for hepatopulmonary syndrome. Clin Gastroenterol Hepatol: 2007; 5 6 749 754
173. Berthelot P, Walker JG, Sherlock S, Reid L. Arterial changes in the lungs in cirrhosis of the liverlung spider nevi. N Engl J Med: 1966; 274 6 291 298
174. Agusti AGN, Roca J, Rodriguez-Roisin R, Mastai R, Wagner PD, Bosch J. Pulmonary hemodynamics and gas exchange during exercise in liver cirrhosis. Am Rev Respir Dis: 1989; 139 2 485 491 (Pubitemid 19057430)
175. Krowka MJ, Dickson ER, Cortese DA. Hepatopulmonary syndrome: clinical observations and lack of therapeutic response to somatostatin analogue. Chest: 1993; 104 2 515 521 (Pubitemid 23229526)
176. Krowka MJ. Clinical management of hepatopulmonary syndrome. Semin Liver Dis: 1993; 13 4 414 422 (Pubitemid 24007144)
177. Rolla G, Brussino L, Colagrande P., et al. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology: 1997; 26 4 842 847 (Pubitemid 27413646)
178. Vachiry F, Moreau R, Hadengue A., et al. Hypoxemia in patients with cirrhosis: relationship with liver failure and hemodynamic alterations. J Hepatol: 1997; 27 3 492 495 (Pubitemid 27390896)
179. Krowka MJ, Wiseman GA, Burnett OL., et al. Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. Chest: 2000; 118 3 615 624
180. Whyte MK, Hughes JM, Peters AM, Ussov W, Patel S, Burroughs AK. Analysis of intrapulmonary right to left shunt in the hepatopulmonary syndrome. J Hepatol: 1998; 29 1 85 93 (Pubitemid 28307987)
181. Fallon MB, Abrams GA. Pulmonary dysfunction in chronic liver disease. Hepatology: 2000; 32 4 Pt 1 859 865
182. Battaglia SE, Pretto JJ, Irving LB, Jones RM, Angus PW. Resolution of gas exchange abnormalities and intrapulmonary shunting following liver transplantation. Hepatology: 1997; 25 5 1228 1232 (Pubitemid 27199952)
183. Stoller JK, Moodie D, Schiavone WA., et al. Reduction of intrapulmonary shunt and resolution of digital clubbing associated with primary biliary cirrhosis after liver transplantation. Hepatology: 1990; 11 1 54 58 (Pubitemid 20075102)
184. Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology: 2005; 41 5 1122 1129 (Pubitemid 40593920)
185. Collisson EA, Nourmand H, Fraiman MH., et al. Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome. Liver Transpl: 2002; 8 10 925 931 (Pubitemid 35154023)
186. Taill C, Cadranel J, Bellocq A., et al. Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation: 2003; 75 9 1482 1489, discussion 1446-1447 (Pubitemid 36597282)
187. Arguedas MR, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology: 2003; 37 1 192 197 (Pubitemid 36042160)
188. Fallon MB. Hepatopulmonary syndrome: more than just a matter of tone? Hepatology: 2006; 43 5 912 914 (Pubitemid 43724615)
189. Mantz FA Jr, Craige E. Portal axis thrombosis with spontaneous portacaval shunt and resultant cor pulmonale. AMA Arch Pathol: 1951; 52 1 91 97
190. Badesch DB, Champion HC, Sanchez MA., et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol: 2009; 54 1, Suppl S55 S66
191. Hoeper MM. Definition, classification, and epidemiology of pulmonary arterial hypertension. Semin Respir Crit Care Med: 2009; 30 4 369 375
192. Lebrec D, Capron JP, Dhumeaux D, Benhamou JP. Pulmonary hypertension complicating portal hypertension. Am Rev Respir Dis: 1979; 120 4 849 856 (Pubitemid 10194952)
193. Mandell MS, Groves BM. Pulmonary hypertension in chronic liver disease. Clin Chest Med: 1996; 17 1 17 33 (Pubitemid 26100791)
194. Panos RJ, Baker SK. Mediators, cytokines, and growth factors in liver-lung interactions. Clin Chest Med: 1996; 17 1 151 169
195. Egermayer P, Town GI, Peacock AJ. Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension. Thorax: 1999; 54 2 161 168 (Pubitemid 29101362)
196. Maruyama T, Ohsaki K, Shimoda S, Kaji Y, Harada M. Thromboxane-dependent portopulmonary hypertension. Am J Med: 2005; 118 1 93 94
197. Nichols WC, Koller DL, Slovis B., et al. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nat Genet: 1997; 15 3 277 280 (Pubitemid 27098722)
198. Deng Z, Haghighi F, Helleby L., et al. Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33. Am J Respir Crit Care Med: 2000; 161 3 Pt 1 1055 1059 (Pubitemid 30171772)
199. Deng Z, Morse JH, Slager SL., et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet: 2000; 67 3 737 744 (Pubitemid 30659603)
200. Kimura N, Matsuo R, Shibuya H, Nakashima K, Taga T. BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J Biol Chem: 2000; 275 23 17647 17652 (Pubitemid 30430812)
201. Kawut SM, Krowka MJ, Trotter JF., et al. Pulmonary Vascular Complications of Liver Disease Study Group. Clinical risk factors for portopulmonary hypertension. Hepatology: 2008; 48 1 196 203 (Pubitemid 351975544)
202. Edwards BS, Weir EK, Edwards WD, Ludwig J, Dykoski RK, Edwards JE. Coexistent pulmonary and portal hypertension: morphologic and clinical features. J Am Coll Cardiol: 1987; 10 6 1233 1238 (Pubitemid 18004673)
203. Schraufnagel DE, Kay JM. Structural and pathologic changes in the lung vasculature in chronic liver disease. Clin Chest Med: 1996; 17 1 1 15 (Pubitemid 26100790)
204. Robalino BD, Moodie DS. Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. J Am Coll Cardiol: 1991; 17 2 492 498
205. Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology: 2006; 44 6 1502 1510 (Pubitemid 44953655)
206. Colle IO, Moreau R, Godinho E., et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology: 2003; 37 2 401 409 (Pubitemid 36152540)
207. Murray KF, Carithers RL Jr.; AASLD. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology: 2005; 41 6 1407 1432 (Pubitemid 40770295)
208. Krowka MJ. Portopulmonary hypertension: diagnostic advances and caveats. Liver Transpl: 2003; 9 12 1336 1337
209. Hoeper MM, Rubin LJ. Update in pulmonary hypertension 2005. Am J Respir Crit Care Med: 2006; 173 5 499 505
210. McLaughlin VV, McGoon MD. Pulmonary arterial hypertension. Circulation: 2006; 114 13 1417 1431 (Pubitemid 44454562)
211. Rubin LJ. Primary pulmonary hypertension. N Engl J Med: 1997; 336 2 111 117 (Pubitemid 27020889)
212. Rich S. The medical treatment of primary pulmonary hypertension. Proven and promising strategies. Chest: 1994; 105 2, Suppl 17S 20S (Pubitemid 24068301)
213. Friedman R, Mears JG, Barst RJ. Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension. Circulation: 1997; 96 9 2782 2784 (Pubitemid 27500070)
214. Wells JT, Runo JR, Lucey MR. Portopulmonary hypertension. Hepatology: 2008; 48 1 13 15 (Pubitemid 351975526)
215. Tan HP, Markowitz JS, Montgomery RA., et al. Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol. Liver Transpl: 2001; 7 8 745 749 (Pubitemid 32771477)
216. Kett DH, Acosta RC, Campos MA, Rodriguez MJ, Quartin AA, Schein RM. Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation. Liver Transpl: 2001; 7 7 645 648 (Pubitemid 32677891)
217. Koneru B, Ahmed S, Weisse AB, Grant GP, McKim KA. Resolution of pulmonary hypertension of cirrhosis after liver transplantation. Transplantation: 1994; 58 10 1133 1135 (Pubitemid 24377934)
218. De Wolf AM, Scott VL, Gasior T, Kang Y. Pulmonary hypertension and liver transplantation. Anesthesiology: 1993; 78 1 213 214
219. Schott R, Chaouat A, Launoy A, Pottecher T, Weitzenblum E. Improvement of pulmonary hypertension after liver transplantation. Chest: 1999; 115 6 1748 1749 (Pubitemid 29275676)
220. Kawut SM, Taichman DB, Ahya VN., et al. Hemodynamics and survival of patients with portopulmonary hypertension. Liver Transpl: 2005; 11 9 1107 1111 (Pubitemid 41341761)
221. Cardenas A, Kelleher T, Chopra S. Review article: hepatic hydrothorax. Aliment Pharmacol Ther: 2004; 20 3 271 279 (Pubitemid 39062129)
222. Strauss RM, Boyer TD. Hepatic hydrothorax. Semin Liver Dis: 1997; 17 3 227 232 (Pubitemid 27388060)
223. Xiol X, Guardiola J. Hepatic hydrothorax. Curr Opin Pulm Med: 1998; 4 4 239 242 (Pubitemid 128354976)
224. Kinasewitz GT, Keddissi JI. Hepatic hydrothorax. Curr Opin Pulm Med: 2003; 9 4 261 265 (Pubitemid 36741315)
225. Huang PM, Chang YL, Yang CY, Lee YC. The morphology of diaphragmatic defects in hepatic hydrothorax: thoracoscopic finding. J Thorac Cardiovasc Surg: 2005; 130 1 141 145
226. Mouroux J, Perrin C, Venissac N, Blaive B, Richelme H. Management of pleural effusion of cirrhotic origin. Chest: 1996; 109 4 1093 1096 (Pubitemid 26113657)
227. Zenda T, Miyamoto S, Murata S, Mabuchi H. Detection of diaphragmatic defect as the cause of severe hepatic hydrothorax with magnetic resonance imaging. Am J Gastroenterol: 1998; 93 11 2288 2289 (Pubitemid 29076896)
228. Crdenas A, Arroyo V. Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites. Best Pract Res Clin Endocrinol Metab: 2003; 17 4 607 622
229. Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med: 1999; 107 3 262 267 (Pubitemid 29421593)
230. Serrat J, Roza JJ, Planella T. Hepatic hydrothorax in the absence of ascites: respiratory failure in a cirrhotic patient. Anesth Analg: 2004; 99 6 1803 1804 (Pubitemid 39551924)
231. Alagiakrishnan K, Patel PJ. Left-sided hepatic hydrothorax with ascites. Int J Clin Pract: 1999; 53 3 225 226 (Pubitemid 29201931)
232. Xiol X, Castellote J, Cortes-Beut R, Delgado M, Guardiola J, Ses E. Usefulness and complications of thoracentesis in cirrhotic patients. Am J Med: 2001; 111 1 67 69 (Pubitemid 32635264)
233. Xiol X, Castellv JM, Guardiola J., et al. Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology: 1996; 23 4 719 723 (Pubitemid 26111983)
234. Xiol X, Tremosa G, Castellote J., et al. Liver transplantation in patients with hepatic hydrothorax. Transpl Int: 2005; 18 6 672 675 (Pubitemid 41726831)
235. Strauss RM, Martin LG, Kaufman SL, Boyer TD. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol: 1994; 89 9 1520 1522 (Pubitemid 24313045)
236. Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rössle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol: 2001; 13 5 529 534 (Pubitemid 32466255)
237. Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol: 2002; 13 4 385 390 (Pubitemid 34298817)
238. Conklin LD, Estrera AL, Weiner MA, Reardon PR, Reardon MJ. Transjugular intrahepatic portosystemic shunt for recurrent hepatic hydrothorax. Ann Thorac Surg: 2000; 69 2 609 611 (Pubitemid 30125602)
239. Rössle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut: 2010; 59 7 988 1000
240. Dhanasekaran R, West JK, Gonzales PC., et al. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis. Am J Gastroenterol: 2010; 105 3 635 641
241. Borchardt J, Smirnov A, Metchnik L, Malnick S. Treating hepatic hydrothorax. BMJ: 2003; 326 7392 751 752
242. Runyon BA, Greenblatt M, Ming RH. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol: 1986; 81 7 566 567 (Pubitemid 16097223)
243. Liu LU, Haddadin HA, Bodian CA., et al. Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest: 2004; 126 1 142 148 (Pubitemid 38943130)